AnaptysBio Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

AnaptysBio is a biotechnology-focused company that concentrates on the financial aspects of its collaborations rather than the scientific development itself. It exclusively oversees the financial components of the Jemperli collaboration with GSK and the imsidolimab arrangement with Vanda, with a mandate to protect and return the value of the related royalties to shareholders. The company is based in San Diego, California, and operates within the biotechnology research sector.

Its business activity centers on managing royalty-driven collaborations with pharmaceutical partners. In May 2026, AnaptysBio announced the appointment of Christopher Murphy as Chief Financial Officer and Owen Hughes as a member of its Board of Directors.

Sign up for free to view info

Company overview Employee directory